Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide.
about
Science review: role of coagulation protease cascades in sepsisBench-to-bedside review: acute respiratory distress syndrome - how neutrophils migrate into the lung.Pneumonia, thrombosis and vascular diseaseEffect of LLLT Ga-Al-As (685 nm) on LPS-induced inflammation of the airway and lung in the rat.Low level laser therapy (LLLT) decreases pulmonary microvascular leakage, neutrophil influx and IL-1beta levels in airway and lung from rat subjected to LPS-induced inflammation.Tissue factor-factor VIIa signaling.Prehospital use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a reduced incidence of trauma-induced coagulopathyMycobacterium tuberculosis infection and tissue factor expression in macrophages.Role of tissue factor in Mycobacterium tuberculosis-induced inflammation and disease pathogenesis.Tissue factor, blood coagulation, and beyond: an overview.Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae Pneumonia.Up-regulation of tissue factor in human pulmonary artery endothelial cells after ultrafine particle exposureTissue factor upregulation drives a thrombosis-inflammation circuit in relation to cardiovascular complications.Inhalation of activated protein C inhibits endotoxin-induced pulmonary inflammation in mice independent of neutrophil recruitment.Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.Coagulopathy as a prognostic factor of acute lung injury in childrenTissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection.Regulation of alveolar procoagulant activity and permeability in direct acute lung injury by lung epithelial tissue factor.Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndromeEarly coagulation events induce acute lung injury in a rat model of blunt traumatic brain injury.Monitoring of endothelial dysfunction in critically ill patients: the role of endothelial progenitor cells.A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumoniaTissue factor as an initiator of coagulation and inflammation in the lung.Beyond antibiotics in severe community-acquired pneumonia: the role and rationale for tissue factor pathway inhibition.A review of pulmonary coagulopathy in acute lung injury, acute respiratory distress syndrome and pneumonia.Activation of PPARα by Wy-14643 ameliorates systemic lipopolysaccharide-induced acute lung injury.Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndromeSystemic versus localized coagulation activation contributing to organ failure in critically ill patients.Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome.Protein C and acute inflammation: a clinical and biological perspective.Inhibition of calcium-independent phospholipase A2 prevents inflammatory mediator production in pulmonary microvascular endothelium.Relative Tissue Factor Deficiency Attenuates Ventilator-Induced Coagulopathy but Does Not Protect against Ventilator-Induced Lung Injury in Mice.Tissue factor haploinsufficiency during endotoxin induced coagulation and inflammation in mice.Differential regulation of human lung epithelial and endothelial barrier function by thrombin.Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress.Endothelial cell prostaglandin I(2) and platelet-activating factor production are markedly attenuated in the calcium-independent phospholipase A(2)beta knockout mousePulmonary coagulopathy: a potential therapeutic target in different forms of lung injury.Nebulized anticoagulants in lung injury in critically ill patients-an updated systematic review of preclinical and clinical studies.Influence of endotoxin-induced acute lung injury on pulmonary innate and adaptive immunity.The complex role of fibrin in acute lung injury.
P2860
Q24794146-C975599C-5C83-4215-86E4-2B76F10F534AQ24800620-DB5DB491-9EEA-4B56-8FB9-054E765D9563Q26853685-3AAEB37E-AE1D-4CA4-B7AA-E6E284D902E8Q33217428-E97BACC3-6DDD-4296-AA8E-61D8728787D3Q33329111-640CE7A6-4C27-40D3-AD46-6DBFD42D9C64Q33726774-9C680C19-639E-47C9-8E63-9A2E41B32656Q33896084-958AA691-0C6D-4D27-AB2A-BBAA6ABCAD1BQ34429846-268D8460-6C05-41C6-A70A-D48F1577B85BQ34612375-752FE539-961F-49DA-BCBC-5FD98D68F8F4Q35222618-22DBD2F4-E193-477E-A43E-6CB2DA9B1E20Q35636201-42E79A7F-768D-42B9-A78E-D84FD1CFCC66Q35752422-A3D4FDC4-AA72-44AE-82AE-E6F698DAC197Q35992662-01888A65-7985-470C-B148-5CBF5F3E05EEQ36054354-8447C3B3-BE4B-44DD-B131-20E5838AC32BQ36467694-19DE1735-9180-4699-8269-DCF9B92EAD29Q36472995-BAAF1A9F-3EB6-4770-8153-931A4B24E774Q36540595-45F85C98-8CF7-4841-82DC-F42D07E1EFFFQ36549153-29A7FF72-C187-4B94-AD2B-0374B947A6C3Q36835719-CE9B6AA2-4BC1-4228-9FC2-D538C35C7174Q37139566-D4753780-38BB-40A7-BA54-87D94A8A4CEDQ37158426-56F2C7F9-2A47-491D-8403-62242C769447Q37210059-07DAD518-7CA9-40B3-B5BE-F243CCEB95D2Q37357364-A0AB3881-31E4-4A0C-B341-AC508067D473Q37357367-763D1BB6-33F2-477D-9642-E2CFFBC5B98EQ37394274-3BD21CA9-8CC2-4F7D-A3CE-AE66E2ABC85BQ37407237-7FE8C747-DCFA-4934-A7C1-9D8965EC0943Q37852747-70D9D127-6F81-438E-92A8-8DB38A15BD23Q37909137-7D9FB4B7-6FC0-4B67-8835-1179F4EC1E60Q38056776-7E6CA804-5031-474C-95B3-B0A9615951BAQ38126264-B248D800-F26C-44E3-A13B-DFD205439AB9Q39791311-1E86D04B-3096-449A-8A76-91C8351A4BC9Q39802234-E8321043-650F-4DB6-B2D7-D2FA863337D4Q40478245-70E9AF76-5B11-493E-8451-F6F5573FA482Q40530274-FD47F776-213E-487C-89F4-54DB44902D0BQ40651405-DE8FBE15-47FF-4B6D-9C65-781BEBD3E84BQ41955516-81D78A01-FD8B-463E-8433-2B4F508D20E7Q42764805-4AD4D690-F6C6-4C4F-831B-14AF74E4DDA7Q47097092-2248A1B6-B1AD-40C0-92FE-A121843A1A2FQ47728139-80B03F42-0C97-4E5B-BF1A-B275ECEFD62BQ55051277-ADCB2A01-2807-4967-99E6-6CC4121C2D6E
P2860
Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Extrinsic coagulation blockade ...... ratracheal lipopolysaccharide.
@en
Extrinsic coagulation blockade ...... ratracheal lipopolysaccharide.
@nl
type
label
Extrinsic coagulation blockade ...... ratracheal lipopolysaccharide.
@en
Extrinsic coagulation blockade ...... ratracheal lipopolysaccharide.
@nl
prefLabel
Extrinsic coagulation blockade ...... ratracheal lipopolysaccharide.
@en
Extrinsic coagulation blockade ...... ratracheal lipopolysaccharide.
@nl
P2093
P2860
P356
P1476
Extrinsic coagulation blockade ...... ratracheal lipopolysaccharide.
@en
P2093
Andrew Ghio
Claude A Piantadosi
Debra L Miller
Hagir Suliman
Karen Welty-Wolf
Martha Sue Carraway
Mirella Ezban
P2860
P304
P356
10.1165/AJRCMB.26.6.4688
P577
2002-06-01T00:00:00Z